NDC 51662-1418

NALBUPHINE HCI

Nalbuphine Hci

NALBUPHINE HCI is a Intramuscular; Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Nalbuphine Hydrochloride.

• Product ID: 51662-1418_9614a150-e7b3-4d16-e053-2995a90a042f
• NDC: 51662-1418
• Product Type: Human Prescription Drug
• Proprietary Name: NALBUPHINE HCI
• Generic Name: Nalbuphine Hci
• Dosage Form: Injection, Solution
• Route of Administration: INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
• Marketing Start Date: 2019-10-29
• Marketing Category: ANDA / ANDA
• Application Number: ANDA070918
• Labeler Name: HF Acquisition Co LLC, DBA HealthFirst
• Substance Name: NALBUPHINE HYDROCHLORIDE
• Active Ingredient Strength: 20 mg/mL
• Pharm Classes: Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 51662-1418-1

1 VIAL, MULTI-DOSE in 1 CARTON (51662-1418-1) > 10 mL in 1 VIAL, MULTI-DOSE

• Marketing Start Date: 2019-10-29
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51662-1418-1 [51662141801]

NALBUPHINE HCI INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA070918
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-10-29

Drug Details

Active Ingredients

Ingredient	Strength
NALBUPHINE HYDROCHLORIDE	20 mg/mL

Pharmacological Class

• Competitive Opioid Antagonists [MoA]
• Opioid Agonist/Antagonist [EPC]
• Partial Opioid Agonists [MoA]

NDC Crossover Matching brand name "NALBUPHINE HCI" or generic name "Nalbuphine Hci"

NDC	Brand Name	Generic Name
51662-1418	NALBUPHINE HCI	NALBUPHINE HCI
51662-1420	NALBUPHINE HCI	NALBUPHINE HCI